Clarivate Plc (NYSE:CLVT – Get Free Report) was the target of a large decrease in short interest in August. As of August 31st, there was short interest totalling 26,460,000 shares, a decrease of 9.9% from the August 15th total of 29,370,000 shares. Based on an average trading volume of 4,380,000 shares, the short-interest ratio is currently 6.0 days. Currently, 6.2% of the shares of the stock are short sold.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on the company. Barclays decreased their price target on Clarivate from $6.00 to $5.00 and set an “underweight” rating on the stock in a report on Wednesday, August 7th. Royal Bank of Canada reduced their target price on Clarivate from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research note on Wednesday, August 7th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Clarivate currently has a consensus rating of “Hold” and a consensus target price of $7.75.
Check Out Our Latest Research Report on CLVT
Insider Transactions at Clarivate
Hedge Funds Weigh In On Clarivate
A number of hedge funds and other institutional investors have recently made changes to their positions in CLVT. Baupost Group LLC MA boosted its position in Clarivate by 27.2% during the second quarter. Baupost Group LLC MA now owns 38,929,635 shares of the company’s stock valued at $221,510,000 after purchasing an additional 8,331,233 shares in the last quarter. Norges Bank bought a new stake in Clarivate during the fourth quarter valued at about $54,457,000. Glenview Capital Management LLC boosted its position in Clarivate by 22.2% during the fourth quarter. Glenview Capital Management LLC now owns 24,651,047 shares of the company’s stock valued at $228,269,000 after purchasing an additional 4,472,302 shares in the last quarter. Capital World Investors bought a new stake in Clarivate during the first quarter valued at about $30,104,000. Finally, Edmond DE Rothschild Holding S.A. bought a new stake in Clarivate during the fourth quarter valued at about $25,576,000. Institutional investors own 85.72% of the company’s stock.
Clarivate Stock Up 2.7 %
Shares of CLVT traded up $0.18 during midday trading on Wednesday, reaching $6.82. 3,124,806 shares of the stock were exchanged, compared to its average volume of 4,337,151. Clarivate has a 52 week low of $4.97 and a 52 week high of $9.60. The company has a current ratio of 0.90, a quick ratio of 0.90 and a debt-to-equity ratio of 0.83. The company’s 50 day moving average is $6.39 and its two-hundred day moving average is $6.45. The company has a market capitalization of $4.56 billion, a P/E ratio of -4.11, a PEG ratio of 3.24 and a beta of 1.17.
Clarivate (NYSE:CLVT – Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.02. Clarivate had a positive return on equity of 10.01% and a negative net margin of 46.53%. The business had revenue of $650.30 million for the quarter, compared to the consensus estimate of $651.94 million. During the same quarter in the prior year, the company earned $0.16 EPS. The business’s revenue was down 2.8% compared to the same quarter last year. On average, sell-side analysts anticipate that Clarivate will post 0.64 earnings per share for the current year.
Clarivate Company Profile
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Featured Articles
- Five stocks we like better than Clarivate
- Top Stocks Investing in 5G Technology
- How Much Can You Make in Stocks in One Month?
- Find and Profitably Trade Stocks at 52-Week Lows
- This Is the Top Large-Cap Stock Insiders Are Buying
- What is MarketRank™? How to Use it
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.